Efficacy and safety of a combination treatment of immune checkpoint inhibitors in metastatic breast cancer: a systematic review and meta-analysis.

Ying WangYalan SunFang LuXianghong ZhaoZhenlin NieFeng ZhuBangshun He

Published in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2024)

Pooled therapy had improved PFS in mTNBC patients, especially in patients with PD-L1-positive tumors, and it was less likely to cause grade ≥ 3 AEs.

Keyphrases

metastatic breast cancer
end stage renal disease
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
randomized controlled trial
clinical trial
stem cells
bone marrow
cell therapy
study protocol
combination therapy
open label